ZA200901055B - Oxazolidone derivatives as PR modulators - Google Patents
Oxazolidone derivatives as PR modulatorsInfo
- Publication number
- ZA200901055B ZA200901055B ZA200901055A ZA200901055A ZA200901055B ZA 200901055 B ZA200901055 B ZA 200901055B ZA 200901055 A ZA200901055 A ZA 200901055A ZA 200901055 A ZA200901055 A ZA 200901055A ZA 200901055 B ZA200901055 B ZA 200901055B
- Authority
- ZA
- South Africa
- Prior art keywords
- modulators
- oxazolidone derivatives
- oxazolidone
- derivatives
- Prior art date
Links
- WDGCBNTXZHJTHJ-UHFFFAOYSA-N 2h-1,3-oxazol-2-id-4-one Chemical class O=C1CO[C-]=N1 WDGCBNTXZHJTHJ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83789806P | 2006-08-15 | 2006-08-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200901055B true ZA200901055B (en) | 2009-12-30 |
Family
ID=39082681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200901055A ZA200901055B (en) | 2006-08-15 | 2009-02-13 | Oxazolidone derivatives as PR modulators |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7618990B2 (es) |
| EP (1) | EP2054410A2 (es) |
| JP (1) | JP2010500409A (es) |
| KR (1) | KR20090039774A (es) |
| CN (1) | CN101501031B (es) |
| AR (1) | AR062327A1 (es) |
| AU (1) | AU2007284599B2 (es) |
| BR (1) | BRPI0716622A2 (es) |
| CA (1) | CA2659208A1 (es) |
| CR (1) | CR10617A (es) |
| GT (1) | GT200900032A (es) |
| IL (1) | IL196886A0 (es) |
| MX (1) | MX2009001698A (es) |
| NO (1) | NO20090457L (es) |
| NZ (1) | NZ574753A (es) |
| PE (1) | PE20070753A1 (es) |
| RU (1) | RU2009105113A (es) |
| SA (1) | SA07280440B1 (es) |
| SV (1) | SV2009003168A (es) |
| TW (1) | TW200815428A (es) |
| WO (1) | WO2008021331A2 (es) |
| ZA (1) | ZA200901055B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008112495A1 (en) * | 2007-03-09 | 2008-09-18 | Wyeth | Synthesis and characterization of polymorph form iii of 4-(2,(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile |
| PE20081803A1 (es) * | 2007-03-09 | 2008-12-11 | Wyeth Corp | Sintesis y caracterizacion de la forma ii polimorfica de 4-(2-(4,4-dimetil-2-oxooxazolidin-3-il)tiazol-4-il)benzonitrilo |
| CN101525310B (zh) * | 2009-04-21 | 2019-04-16 | 大连九信精细化工有限公司 | 1-苯甲酰基-3-(2-羟基-1，1-二甲基乙基)硫脲的合成方法 |
| WO2012047617A1 (en) * | 2010-09-28 | 2012-04-12 | Radius Health, Inc. | Selective androgen receptor modulators |
| BR112013010372A2 (pt) * | 2010-12-14 | 2016-07-05 | Merck Sharp & Dohme | composto, e, método para preparar um composto |
| SI3511319T1 (sl) * | 2014-07-03 | 2023-10-30 | Celgene Quanticel Research, Inc. | Inhibitorji lizin specifične demetilaze-1 |
| JP7729831B2 (ja) * | 2020-03-26 | 2025-08-26 | ヤンセン ファーマシューティカ エヌ．ベー． | モノアシルグリセロールリパーゼ調節因子としてのアミノシクロブタン |
| CN118146123A (zh) * | 2024-02-04 | 2024-06-07 | 河北鼎泰制药有限公司 | 一种盐酸安罗替尼中间体的合成方法 |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670338A1 (de) * | 1966-03-14 | 1972-08-10 | Heyden Chem Fab | Verfahren zur Herstellung von antimikrobiell wirksamen Nitrofuranderivaten |
| US3493565A (en) | 1966-03-14 | 1970-02-03 | Squibb & Sons Inc | 3-amino-5-(nitrofuryl)-1,2,4-oxadiazole derivatives |
| NL6809997A (es) * | 1967-08-04 | 1969-02-06 | ||
| GB1224995A (en) | 1968-09-20 | 1971-03-10 | Delalande Sa | New 5-propargyloxymethyl-2-substituted oxazolidinones and their process of preparation |
| CA1076582A (en) * | 1975-10-28 | 1980-04-29 | Charles J. Paget | Antiviral thiazolinyl or thiazinyl ketobenzimidazoles |
| US4293558A (en) * | 1975-10-28 | 1981-10-06 | Eli Lilly And Company | Antiviral thiazolinyl benzimidazoles and derivatives |
| US4008243A (en) * | 1975-11-19 | 1977-02-15 | Eli Lilly And Company | Antiviral thiazolinyl or thiazinyl benzimidazole esters |
| US4268679A (en) * | 1980-02-19 | 1981-05-19 | Ppg Industries, Inc. | 3-[5- or 3-Substituted-5- or 3-isoxazolyl]-1-allyl or alkyl-4-substituted-5-substituted or unsubstituted-2-imidazolidinones |
| US4426527A (en) * | 1982-02-12 | 1984-01-17 | Ppg Industries, Inc. | 3-[5- Or 3-substituted-1,2,4-oxadiazol-3- or -5-yl]-1-substituted-4-substituted-5-substituted or unsubstituted-2-imidazolidinones |
| DE3227329A1 (de) | 1982-07-22 | 1984-01-26 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von 2-n,n-disubstituierten aminothiazolen |
| US4756744A (en) * | 1985-06-24 | 1988-07-12 | Ppg Industries, Inc. | Herbicidally active 4-aminoalkylamino-3-isoxazolyl-2-imidazolidinone derivatives |
| DE3723797A1 (de) | 1987-07-18 | 1989-01-26 | Merck Patent Gmbh | Oxazolidinone |
| KR930703262A (ko) | 1990-11-06 | 1993-11-29 | 스튜어트 알. 슈터 | 이미다졸리디논 화합물 |
| DK0934937T3 (da) | 1990-11-30 | 2002-04-02 | Otsuka Pharma Co Ltd | Azolderivater som superoxidradikalinhibitor |
| DE4335876A1 (de) * | 1993-10-17 | 1995-04-20 | Schering Ag | Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen |
| JPH07149745A (ja) | 1993-11-30 | 1995-06-13 | Hisamitsu Pharmaceut Co Inc | 新規な２−アミノチアゾール誘導体 |
| WO1995015955A1 (de) | 1993-12-06 | 1995-06-15 | Basf Aktiengesellschaft | 2,4-diaminothiazole und ihre herstellung |
| DE4425613A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| DE19540027A1 (de) | 1995-10-27 | 1997-04-30 | Gruenenthal Gmbh | Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe |
| US5714607A (en) * | 1995-12-01 | 1998-02-03 | American Cyanamid Company | Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
| DE19601264A1 (de) * | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
| DE19649095A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue Heteroaryl-Oxazolidinone |
| HRP970049A2 (en) | 1996-02-06 | 1998-04-30 | Bayer Ag | New heteroaryl oxazolidinones |
| DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| US5972372A (en) * | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
| JP3192662B2 (ja) | 1996-07-31 | 2001-07-30 | 日研化学株式会社 | ６―フェニルテトラヒドロ―１，３―オキサジン―２―オン誘導体及びそれを含む医薬組成物 |
| US5819742A (en) * | 1996-11-06 | 1998-10-13 | Family Health International | Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both |
| DE19732928C2 (de) | 1997-07-31 | 2000-05-18 | Gruenenthal Gmbh | Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel |
| JPH11193281A (ja) * | 1997-10-27 | 1999-07-21 | Takeda Chem Ind Ltd | アデノシンａ３受容体拮抗剤およびチアゾール化合物 |
| US6562844B2 (en) * | 1998-01-23 | 2003-05-13 | Pharmacia & Upjohn Company | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| CN1288462A (zh) * | 1998-01-23 | 2001-03-21 | 法玛西雅厄普约翰美国公司 | 噁唑烷酮组合库、组合物和制备方法 |
| AU3289299A (en) | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
| JP2001261652A (ja) | 2000-03-21 | 2001-09-26 | Suntory Ltd | 二置換イミノヘテロサイクリック化合物 |
| WO2001074811A2 (en) | 2000-03-30 | 2001-10-11 | Takeda Chemical Industries, Ltd. | Substituted 1,3-thiazole compounds, their production and use |
| GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| DE10034628A1 (de) | 2000-07-17 | 2002-01-31 | Bayer Ag | Pyridinhaltige Oxazolidinone als Cytokin-Inhibitoren |
| DE10034623A1 (de) | 2000-07-17 | 2002-01-31 | Bayer Ag | Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren |
| DE10034622A1 (de) | 2000-07-17 | 2002-01-31 | Bayer Ag | Substituierte Imidazol-Derivate und deren Verwendung zur Herstellung von Arzneimitteln |
| US20020115669A1 (en) * | 2000-08-31 | 2002-08-22 | Wiedeman Paul E. | Oxazolidinone chemotherapeutic agents |
| FR2823209B1 (fr) | 2001-04-04 | 2003-12-12 | Fournier Lab Sa | Nouvelles thiohydantoines et leur utilisation en therapeutique |
| GB0118407D0 (en) | 2001-07-27 | 2001-09-19 | Cipla Ltd | Oxazolidinone derivatives as antibacterial agents |
| KR100437972B1 (ko) * | 2001-10-27 | 2004-07-02 | 한국과학기술연구원 | 피롤리디논 유도체, 이의 제조 방법 및 이를 포함하는제약 조성물 |
| US7119111B2 (en) | 2002-05-29 | 2006-10-10 | Amgen, Inc. | 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| MXPA05001544A (es) | 2002-08-08 | 2005-04-19 | Smithkline Beecham Corp | Compuestos de tiofeno. |
| TWI324596B (en) * | 2002-08-26 | 2010-05-11 | Nat Health Research Institutes | Imidazolamino compounds |
| WO2004019938A1 (en) | 2002-08-28 | 2004-03-11 | Merck Frosst Canada & Co. | Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma |
| US20040167192A1 (en) * | 2003-01-16 | 2004-08-26 | David Solow-Cordero | Methods of treating conditions associated with an Edg-7 receptor |
| US7169797B2 (en) * | 2003-02-14 | 2007-01-30 | Abbott Laboratories | Protein-tyrosine phosphatase inhibitors and uses thereof |
| AU2004225965A1 (en) | 2003-03-25 | 2004-10-14 | Vertex Pharmaceuticals Incorporated | Thiazoles useful as inhibitors of protein kinases |
| WO2004089303A2 (en) | 2003-04-03 | 2004-10-21 | Merck & Co., Inc. | Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| BRPI0412382A (pt) | 2003-07-08 | 2006-09-19 | Astrazeneca Ab | composto , método para a verificação de novos compostos medicinais que se ligam a e modulam a atividade, por agonismo , agonismo parcial, ou antagonismo, do receptor de acetilcolina nicotìnico alfa7, método de tratamento ou profilaxia de uma doença ou condição humana, método para tratamento de jetlag, induzindo interrupção de fumar, vìcio em nicotina, abstinência, dor, e para colite ulcerativa, composição farmacêutica, e, método de tratamento ou prevenção de uma condição ou distúrbio que surge da disfunção de neurotransmissão do receptor de acetilcolina nicotìnico em um mamìfero, e, uso de um composto |
-
2007
- 2007-07-31 TW TW096127981A patent/TW200815428A/zh unknown
- 2007-08-10 AR ARP070103552A patent/AR062327A1/es not_active Application Discontinuation
- 2007-08-13 NZ NZ574753A patent/NZ574753A/en not_active IP Right Cessation
- 2007-08-13 JP JP2009524654A patent/JP2010500409A/ja active Pending
- 2007-08-13 US US11/891,748 patent/US7618990B2/en not_active Expired - Fee Related
- 2007-08-13 CA CA002659208A patent/CA2659208A1/en not_active Abandoned
- 2007-08-13 CN CN2007800302230A patent/CN101501031B/zh not_active Expired - Fee Related
- 2007-08-13 MX MX2009001698A patent/MX2009001698A/es active IP Right Grant
- 2007-08-13 EP EP07836789A patent/EP2054410A2/en not_active Withdrawn
- 2007-08-13 KR KR1020097002974A patent/KR20090039774A/ko not_active Ceased
- 2007-08-13 AU AU2007284599A patent/AU2007284599B2/en not_active Ceased
- 2007-08-13 WO PCT/US2007/017931 patent/WO2008021331A2/en not_active Ceased
- 2007-08-13 RU RU2009105113/04A patent/RU2009105113A/ru not_active Application Discontinuation
- 2007-08-13 BR BRPI0716622-2A patent/BRPI0716622A2/pt not_active IP Right Cessation
- 2007-08-14 SA SA07280440A patent/SA07280440B1/ar unknown
- 2007-08-15 PE PE2007001100A patent/PE20070753A1/es not_active Application Discontinuation
-
2009
- 2009-01-29 NO NO20090457A patent/NO20090457L/no not_active Application Discontinuation
- 2009-02-03 IL IL196886A patent/IL196886A0/en unknown
- 2009-02-12 SV SV2009003168A patent/SV2009003168A/es unknown
- 2009-02-12 GT GT200900032A patent/GT200900032A/es unknown
- 2009-02-13 ZA ZA200901055A patent/ZA200901055B/xx unknown
- 2009-02-13 CR CR10617A patent/CR10617A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200815428A (en) | 2008-04-01 |
| EP2054410A2 (en) | 2009-05-06 |
| CN101501031A (zh) | 2009-08-05 |
| CA2659208A1 (en) | 2008-02-21 |
| AR062327A1 (es) | 2008-10-29 |
| NZ574753A (en) | 2011-04-29 |
| PE20070753A1 (es) | 2008-08-14 |
| KR20090039774A (ko) | 2009-04-22 |
| SA07280440B1 (ar) | 2010-10-20 |
| IL196886A0 (en) | 2009-11-18 |
| WO2008021331A2 (en) | 2008-02-21 |
| MX2009001698A (es) | 2009-02-25 |
| CN101501031B (zh) | 2012-02-01 |
| AU2007284599A1 (en) | 2008-02-21 |
| NO20090457L (no) | 2009-04-27 |
| AU2007284599B2 (en) | 2011-07-21 |
| BRPI0716622A2 (pt) | 2013-10-08 |
| CR10617A (es) | 2009-03-12 |
| US7618990B2 (en) | 2009-11-17 |
| US20080045556A1 (en) | 2008-02-21 |
| WO2008021331A3 (en) | 2008-05-22 |
| RU2009105113A (ru) | 2010-09-27 |
| SV2009003168A (es) | 2010-01-14 |
| JP2010500409A (ja) | 2010-01-07 |
| GT200900032A (es) | 2011-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL193176A0 (en) | Benzoyl-piperidine derivatives as 5ht2/d3 modulators | |
| IL194814A0 (en) | Mglur5 modulators i | |
| IL194367A0 (en) | Dihydropyrazolopyrimidinone derivatives | |
| ZA200901336B (en) | Pyridizinone derivatives | |
| IL193641A0 (en) | Spiroindolinone derivatives | |
| ZA200808410B (en) | Pyrrolo-and thiazolo-pyridine compounds as hif modulators | |
| IL195013A0 (en) | Pyridopyrimidinone derivatives | |
| IL198319A0 (en) | Spiroindolinone derivatives | |
| IL195422A0 (en) | 2-pyrazinecarboxamide derivatives | |
| ZA200809800B (en) | 2-Thioxanthine derivatives acting as Mpo-inhibitors | |
| ZA200805574B (en) | Indol-3-yl-carbonyl-spiro-piperidine derivatives | |
| IL197722A0 (en) | Mglur5 modulators | |
| SI2094658T1 (sl) | Spojine tetrahidrociklopenta(b)indola kot modulatorji androgenskega receptorja | |
| IL198059A0 (en) | 2-aminocarbonyl-pyridine derivatives | |
| IL196364A0 (en) | Aminoindazolylurea derivatives | |
| IL196949A0 (en) | 2-aminobenzoxazole carboxamides as 5ht3 modulators | |
| IL193211A0 (en) | Indazole-heteroaryl derivatives | |
| ZA200904028B (en) | 5-Hydroxymethyl-oxazolidin-2-one derivatives | |
| ZA200901055B (en) | Oxazolidone derivatives as PR modulators | |
| IL197152A0 (en) | 5-phenyl-nicotinamide derivatives | |
| ZA200807460B (en) | Spiroindolinone derivatives | |
| ZA200806810B (en) | Benzoyl-piperidine derivatives as 5HT2/D3 modulators | |
| IL197239A0 (en) | Phenyloxyaniline derivatives | |
| GB0614154D0 (en) | Novel Pyriazine Derivatives | |
| HK1131610A (en) | Oxazolidone derivatives as pr modulators |